• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Alta Partners

edit

Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in the industry since 1996. Their diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for their companies and their investors.

Recent Milestones

edit

• 
  Alta Partners invested in Kite Pharma. (5/15/13)
  Posted 5/15/13 at 11:33pm via fiercebiotech.com
• 
  Alta Partners invested in Lumena Pharmaceuticals. (5/8/13)
  Posted 5/10/13 at 2:00am via reuters.com
• 
  Alta Partners invested in Esperion Therapeutics. (4/25/13)
  Posted 4/26/13 at 11:15pm via businesswire.com
• 
  Alta Partners invested in Zafgen. (12/4/12)
  Posted 12/5/12 at 2:43am via masshightech.com
• 
  Alta Partners invested in Kiadis Pharma. (11/20/12)
  Posted 5/7/13 at 5:14am via kiadis.com
• 
  Alta Partners invested in Applied Genetics Technologies Corporation. (11/19/12)
  Posted 11/20/12 at 4:36am via biospace.com
• 
  Alta Partners invested in ZS Pharma. (10/23/12)
  Posted 10/25/12 at 7:16pm via bizjournals.com
• 
  Alta Partners invested in Sutro Biopharma. (5/8/12)
  Posted 5/8/12 at 5:57am via yahoo.com
• 
  Alta Partners invested in SARcode Bioscience. (7/18/11)
  Posted 7/18/11 at 5:31pm via finsmes.com
• 
  Alta Partners invested in Aerie Pharmaceuticals. (3/7/11)
  Posted 3/3/11 at 8:43pm via aeriepharma.com
• 
  Alta Partners invested in Chimerix. (2/14/11)
  Posted 2/14/11 at 8:23pm via chimerix-inc.com
• 
  Alta Partners invested in PneumRx. (1/4/11)
  Posted 1/4/11 at 8:33pm via finsmes.com
• 
  Alta Partners invested in Sutro Biopharma. (11/17/10)
  Posted 11/17/10 at 6:25pm via finsmes.com
• 
  Alta Partners invested in aTyr Pharma. (10/26/10)
  Posted 10/26/10 at 11:01pm via atyrpharma.com
• 
  Alta Partners invested in Pathwork Diagnostics. (10/6/10)
  Posted 10/7/10 at 9:23pm via dowjones.com
• 
  Alta Partners invested in Cerenis Therapeutics. (7/26/10)
  Posted 7/26/10 at 6:18pm via cerenis.com

Investments

Videos

Sources

1. UPDATED: Billionaires back Kite Pharma in $20M raise for cancer immunotherapies (fiercebiotech.com) [edit]
2. Lumena Pharmaceuticals Announces $23 Million Series A Financing (reuters.com) [edit]
3. Esperion Therapeutics Completes $33 Million Preferred Financing to Advance Its Novel Oral LDL-C Lowering Therapy to Later Stage Clinical Trials (businesswire.com) [edit]
4. Obesity drug developer Zafgen raises $21M (masshightech.com) [edit]
5. Kiadis Pharma Raises EUR 10 Million in Financing Round (kiadis.com) [edit]
6. Applied Genetic Technologies Corporation Lands $37.5 Million in Venture Capital Funding (biospace.com) [edit]
7. ZS Pharma lands $46 million for kidney and liver drug development (bizjournals.com) [edit]
8. Sutro Closes $16.5 Million Second Tranche of Series C Financing (finance.yahoo.com) [edit]
9. SARcode Bioscience Closes $44M Series B Financing (finsmes.com) [edit]
10. Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio (aeriepharma.com) [edit]
11. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 (chimerix-inc.com) [edit]
12. PneumRx Raises $33M (finsmes.com) [edit]
13. Sutro Biopharma Secures $36.5M in Series C Financing (finsmes.com) [edit]
14. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor (atyrpharma.com) [edit]
15. Alta Partners Leads $30M Series C For Pathwork Diagnostics (fis.dowjones.com) [edit]
16. Cerenis Therapeutics raises EUR 40 million in series C financing (cerenis.com) [edit]
17. Immune Design Nabs $32M for Targeted Vaccines (xconomy.com) [edit]
18. Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug (fiercebiotech.com) [edit]
19. Trevena, Inc.: Series B $35M (onbiovc.com) [edit]
20. Calistoga Pharmaceuticals Raises $40 Million in Series C Financing (calistogapharma.com) [edit]
21. Nereus Pharmaceuticals, Inc.: Series E $20M (onbiovc.com) [edit]
22. Drug developer Virobay secures $10M for hepatitis C treatments (deals.venturebeat.com) [edit]
23. FoldRx banks $29M for neurodegenerative drug application (fiercebiotech.com) [edit]
24. Achaogen Completes $56 Million Series C Financing (pr-inside.com) [edit]
25. TransMedics, Inc.: Series E $36M (onbiovc.com) [edit]
26. Virobay raises $300K to treat hepatitis C and autoimmune disorders (deals.venturebeat.com) [edit]
27. Coapt Systems takes $3.7M for facial rejuvenation (deals.venturebeat.com) [edit]
28. Metabolex (Metabolex.com) [edit]
29. aTyr Pharma, Inc.: Series C $12M (onbiovc.com) [edit]
30. VC insiders inject $16M into Chimerix (fiercebiotech.com) [edit]
31. Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing (avidrp.com) [edit]
32. Capital Report Index [edit]
33. VCs PIPE $43.5 Million to Sunesis Pharma (pehub.com) [edit]
34. Aerovance inhales $38M for asthma drugs (venturebeat.com) [edit]
35. Sutro Biopharma lands $15M with protein production (bizjournals.com) [edit]
36. Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive (fiercebiotech.com) [edit]
37. Xelerated Closes $13 Million Funding Round (xelerated.com) [edit]
38. Sierra Surgical raises $14.5M for female sterilization (deals.venturebeat.com) [edit]
39. Immune Design Aiming To Make Vaccines That Work Better in a Single Shot (xconomy.com) [edit]
40. Vaccsys raises $9 million for vaccine research (deals.venturebeat.com) [edit]
41. Esperion Therapeutics Completes $22.75M Series A Financing (esperion.com) [edit]
42. Trevena, Inc. Announces $24 Million Series A Financing (trevenainc.com) [edit]
43. Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments (biospace.com) [edit]
44. Taligen Therapeutics Secures Series B Financing (taligentherapeutics.com) [edit]
45. Fundamental Applied Biology raises $21M for making “cell-free” proteins (deals.venturebeat.com) [edit]
46. Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing Daniel S. Gold, PhD, Joins as Chief Executive Officer (sutrobio.com) [edit]
47. Excaliard closes $15.5 million Series A financing from Alta Partners, ProQuest Investments and RiverVest Venture Partners (excaliard.com) [edit]
48. Carbylan Announces $20 Million Series B Financing (carbylan.com) [edit]
49. Agami Systems Raising $50 Million Funding (venturedeal.com) [edit]
50. Sierra Surgical raises $7.1M for female-sterilization tech (deals.venturebeat.com) [edit]
51. Agensys Raises $41 Million (agensys.com) [edit]
52. Paracor raises $44M for heart-failure device that restrains the heart (venturebeat.com) [edit]
53. Ceregene Partners With Genzyme, Inks $28M Series C (altapartners.com) [edit]
54. EDGAR [edit]
55. Carrier Ethernet's Xelerated Ventures Forth With $23M (thealarmclock.com) [edit]
56. Metabolex (Metabolex.com) [edit]
57. aTyr Pharma Completes $10.5M Series B Round (atyrpharma.com) [edit]
58. TransMedics (transmedics.com) [edit]
59. Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more (deals.venturebeat.com) [edit]
60. Aerovance, asthma treatment company, finishes raising $60M (deals.venturebeat.com) [edit]
61. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
62. Intarcia restarts with $50M for hepatitis, diabetes treatments (deals.venturebeat.com) [edit]
63. PHENOMIX COMPLETES $55 MILLION SERIES C FINANCING (phenomixcorp.com) [edit]
64. Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of a $21 million Series A financing (calistogapharma.com) [edit]
65. Sanuras, breat tumor device company raises $15M (deals.venturebeat.com) [edit]
66. SARcode secured $25 million in financing (sarcode.com) [edit]
67. Cara Therapeutics Secures $19 Million in Series C Financing. (thefreelibrary.com) [edit]
68. INTRADIGM ANNOUNCES SIGNIFICANT ENHANCEMENTS OF THE COMPANY CAPABILITIES, A NEW SERIES A FINANCING AND IMPORTANT ADDITION TO SENIOR MANAGEMENT TEAM (intradigm.com) [edit]
69. ChemoCentryx Completes Series C Financing (chemocentryx.com) [edit]
70. MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs (macrogenics.com) [edit]
71. Aegis Semiconductor Secures $8 Million in Series D Financing (aegislightwave.com) [edit]
72. EDGAR [edit]
73. Netli raises $18M funding (sanjose.bizjournals.com) [edit]
74. RedShift Secures $12 Million in First-Round Financing (redshiftsystems.com) [edit]
75. Opal Therapeutics raises $6m in series A funding (lifescientist.com.au) [edit]
76. Xelerated Lands $17 Million in New Funding (xelerated.com) [edit]
77. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]
78. TransMedics (transmedics.com) [edit]